Santa Farma, one of the most prominent domestic pharmaceutical companies in Turkey, entered into another agreement with MEALIS Middle East Life Sciences as part of a strategic cooperation which was formed in 2020.
After signing sales, marketing and distribution agreements for 2 different products used for treatment of iron deficiency anaemia and stress related urinary incontinence in recent years, the two companies entered into a new agreement.
Under the new agreement, MEALIS was granted the right to sell, market and distribute, in Turkey, a drug used for treatment of pain, loss of sensation, loss of strength and similar symptoms affecting the end zones of body due to peripheral neural damage arising from diabetes and known as diabetic neuropathy.
